Precision Neurosciences has closed an impressive $102 million investment round as it races with Elon Musk's Neuralink and others to bring brain-computer interface (BCI) technology to the market. The ...
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States.
Abstract: This paper demonstrates an RF rectifier employing a pixel-like network and an inductive matching technique. The pixel-like network acts as an RF choke and is more compact compared to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results